Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Halozyme Therapeutics (HALO) Q2 2022 Earnings
HALO
-1.45%
10
May
Confirmed
Q3 2021
Q4 2021
Q1 2022
Q2 2022
0.39
0.47
0.54
0.62
Details
Expected EPS
0.49
Actual EPS
0.47
Surprise EPS
-0.02
Surprise Percent
+4.08%
Description
Halozyme Therapeutics (HALO) has reported earnings of 0.47 per share for Q2 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login